(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMYVID

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

AMYVID

ST13

US500000090103024

Class

44

Filing

90103024

Registration

6431765

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

07/27/2026

Classification

Registered

Trademark type

Combined

Nice classes

44

Filing date

08/10/2020

Registration date

07/27/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/27/2021

Last transaction

07/27/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

04/06/2012

First use in commerce

04/06/2012

Drawing code

3

Owner type

03

Owner location

Indianapolis, IN, US

Examiner

HA, PAULINE T.

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the literal element "AMYVID" with a graphic representation of a right and left parentheses.

Holders and representatives

Holders

Eli Lilly and Company

Representatives

Bruce W. Longbottom

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical information services in the field of neurodegenerative amyloid diseases

Publications

History of USPTO decisions and trademark events.

16 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/27/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/27/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/11/2021

PUBO

PUBLISHED FOR OPPOSITION

05/11/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/21/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/22/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/22/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/22/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/09/2020

GNRT

NON-FINAL ACTION E-MAILED

11/09/2020

CNRT

NON-FINAL ACTION WRITTEN

11/09/2020

DOCK

ASSIGNED TO EXAMINER

11/03/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/10/2020

NWAP

NEW APPLICATION ENTERED

08/13/2020

Continuous trademark protection

Get notified about every new filing that threatens AMYVID or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.